A61K 47/00 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Introduced: July 1974
Additional Content IPC
Targeting agent Natural or artificial substances that enhance absorption of a biologically active agent in a particular part of the body – i.e. in a particular organ or to a particular cell type. Pre-targeting system An example of this is an immuno-conjugate that has a part that recognizes a target antigen and a part that recognizes a further substance to which a therapeutic agent is attached. When said conjugate is administered it binds to target cells, furnishing said cells with binding sites for the therapeutic agent. Modifying agent Natural or artificial substances that enhance the physio-chemical properties of a biologically active agent – i.e. that improve long term storage stability or enhance bioavailability when delivered orally. Macromolecular A chemical moiety (organic or inorganic) that is linked to identical sub-units in numbers of greater than 5. Thus, polysiloxanes are classified in , polyphosphazines in and inorganic species such as polyphosphate Chemically bound When two distinct chemical entities are linked to one another by co-valent bonds. An alternative situation may arise when both chemical entities are linked using ionic bonds, for example using organic/inorganic ions that complex with one another, e.g. see Codrug A dimer, oligomer or polymer of one or more pharmacologically or therapeutically active compounds. e.g. polyaspirin
IPC and CPC are identically structured here. All 6 subcodes exist in both systems.
1 shared codes have differing titles between IPC and CPC.
IPC defines codes here since 1990.
Child Classifications
Navigate with arrow keys, Enter to open
- A61K 47/06 Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite since 1990 IPC+CPC Available in IPC and CPC
- A61K 47/30 Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates since 1990 IPC+CPC Available in IPC and CPC
- A61K 47/44 Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin (synthetic glycerides, e.g. medium-chain triglycerides, A61K47/14) since 1990 IPC+CPC Available in IPC and CPC
- A61K 47/46 Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts since 1990 IPC+CPC Available in IPC and CPC
- A61K 47/50 the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates since 2017 IPC+CPC Available in IPC and CPC
Top Applicants
Top Applicants (IPC)
Class A61,2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 18,523
- NOVARTIS CH 14,253
- COVIDIEN US 13,953
- ROCHE CH 12,005
- CHINESE ACADEMY OF SCIENCES 11,955
- UNIVERSITY OF CALIFORNIA US 11,692
- HARVARD UNIVERSITY US 11,596
- L'OREAL FR 11,593
- P&G (PROCTER & GAMBLE COMPANY) US 11,297
- OLYMPUS CORPORATION JP 9,594
Top Applicants (CPC)
Class A61,2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 20,621
- NOVARTIS CH 15,792
- ROCHE CH 14,303
- COVIDIEN US 13,862
- HARVARD UNIVERSITY US 13,454
- UNIVERSITY OF CALIFORNIA US 12,798
- P&G (PROCTER & GAMBLE COMPANY) US 12,140
- L'OREAL FR 11,800
- OLYMPUS CORPORATION JP 9,894
- BOSTON SCIENTIFIC SCIMED US 9,513